SHP-1 encoded by the gene PTPN6 is directly activated by the AHR.
AHR binds to dioxin response elements within the SHP-1 promoter in a TCDD-inducible manner.
TCDD-mediated increase in SHP-1 levels is observed in primary human B cells.
Higher SHP-1 levels help in maintaining high BCL-6 levels in the presence of TCDD.
In the presence of SHP-1 inhibitor, decreased BCL-6 levels are observed.